SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

STAAR Surgical Company (STAA) News

Track canonical SquawkNews coverage tagged to STAA, STAAR Surgical Company. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 28 indexed stories across 12 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol STAA Asset equity Sector Markets 90 days 28 Last 22.745 Updated Sep 29, 2026, 02:26 PM UTC Open live news feed
H CarMax Posts Upbeat Q2 Earnings, Joins Iovance Biotherapeutics, Perella Weinberg Partners And Other Big Stocks Moving Higher On Tuesday U.S. stocks were mixed, with the Dow Jones index falling over 100 points on Tuesday. Shares of Carmax Inc (NYSE: KMX ) rose sharply after the company reported better-than-expected second-quarter financial results. CarMax LIVE | Sep 29, 2026, 02:26 PM UTC L STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know What Happened? Shares of medical lens company STAAR Surgical NASDAQ:STAAjumped 6.4% in the pre-market session after Stifel upgraded the company from Hold to Buy and lifted its price target to $31.00 from $28.00,StreetIns EQUITY | Sep 29, 2026, 02:08 PM UTC L Staar Surgical Raised to Buy From Hold by Stifel Ratings actions from Benzinga NEWS | Sep 29, 2026, 09:28 AM UTC L STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know What Happened? Shares of medical lens company STAAR Surgical NASDAQ:STAAjumped 6.3% in the afternoon session after the company announced that its board of directors authorized a share repurchase program of up to $50 mill EQUITY | Sep 25, 2026, 07:42 PM UTC L Staar Surgical Shares Rise on $50M Buyback Plans By Adriano MarcheseStaar Surgical shares advanced Friday after the company said its board authorized a $50 million share-buyback program.Shares rose 6.3% to $20.27.The vision-correction solutions company said the decisio EQUITY | Sep 25, 2026, 02:59 PM UTC L Staar Surgical Board Approves $50 Million Share Repurchase Authorization STAAR Surgical Company NASDAQ:STAA NEWS | Sep 24, 2026, 10:06 PM UTC L STAAR Surgical Company (STAA) Authorizes Up To $50M Buyback STAAR Surgical Company authorized a share repurchase program for up to $50M over the next 12 months, with timing and amount at its discretion.Material DetailsContext by AI AnalystThis is a capital return move amid manage EQUITY | Sep 24, 2026, 08:01 PM UTC L STAAR Surgical Board Approves $50 Million Share Repurchase Authorization STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that its Board of Directors, at a regularly s NEWS | Sep 24, 2026, 08:01 PM UTC L STAAR Surgical Board Approves $50 Million Share Repurchase Authorization >STAA STAAR Surgical Board Approves $50 Million Share Repurchase Authorization >STAA NEWS | Sep 24, 2026, 08:01 PM UTC L STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today released a new report entitled The Future of Refractive EQUITY | Sep 10, 2026, 11:00 AM UTC L STAAR Surgical appoints David Bailey as chief commercial officer STAAR Surgical appointed David Bailey as chief commercial officer, effective September 8, 2026. EQUITY | Sep 10, 2026, 10:03 AM UTC L Staar Surgical names former CEO Bailey as commercial chief Staar Surgical said David Bailey is expected to rejoin as chief commercial officer to run its commercial operations, according to the implantable lenses maker. EQUITY | Sep 08, 2026, 08:20 PM UTC L STAAR Surgical appoints former CEO David Bailey as CCO STAAR Surgical named former CEO David Bailey as chief commercial officer. EQUITY | Sep 08, 2026, 08:03 PM UTC L STAAR Surgical appoints David Bailey as Chief Commercial Officer STAAR Surgical (STAA) appointed David Bailey as Chief Commercial Officer. Bailey will join the company’s executive team, the firm said. EQUITY | Sep 08, 2026, 08:01 PM UTC L STAAR Surgical appoints Ben Park as Chief Technology Officer STAAR Surgical (STAA) appointed Ben Park, Ph.D., as Chief Technology Officer, adding him to the company’s executive team. EQUITY | Sep 02, 2026, 08:01 PM UTC L STAA Reports Second Quarter 2026 Results STAA reports second quarter 2026 results EARNINGS | Aug 12, 2026, 08:06 PM UTC L STAA Reports $0.16 EPS, 111% Revenue Growth STAA reports $0.16 EPS and $93.5M revenue, up 111% year-over-year EARNINGS | Aug 12, 2026, 08:05 PM UTC L STAA - STAAR Surgical to Host Second Quarter 2026 Earnings Results Call and Webcast on August 12, 2026 STAA - STAAR Surgical to Host Second Quarter 2026 Earnings Results Call and Webcast on August 12, 2026 EARNINGS | Aug 04, 2026, 08:13 PM UTC H STAAR Surgical Appoints Warren Foust as CEO STAAR Surgical names new CEO EQUITY | Aug 04, 2026, 08:11 PM UTC L RXST GKOS SGHT BLCO COO STAA Medical Supplies and Devices initiation - resuming coverage across the Vision sector (Neutral rated GKOS, Neutr RXST GKOS SGHT BLCO COO STAA Medical Supplies and Devices initiation - resuming coverage across the Vision sector (Neutral rated GKOS, Neutral rated RXST, Buy rated SGHT) and initiating coverage of Buy rated BLCO, Neutra EQUITY | Jul 28, 2026, 11:52 AM UTC L STAA Initiated Sell W/$20.00 PT at UBS STAA Initiated Sell W/$20.00 PT at UBS EQUITY | Jul 28, 2026, 11:49 AM UTC L Top Initiations: ATEC BDX BLCO EW SGHT SIBN STE ZBH: BUY @ UBS COO GKOS GMED IART RXST TFX TMDX: NEUTRAL @ UBS INSP STAA: SELL @ UBS BNTC: O Top Initiations: ATEC BDX BLCO EW SGHT SIBN STE ZBH: BUY @ UBS COO GKOS GMED IART RXST TFX TMDX: NEUTRAL @ UBS INSP STAA: SELL @ UBS BNTC: OUTPERFORM @ Wedbush CRWD: BUY @ Loop FTH: OUTPERFORM @ Opp HRB: EQUAL WEIGHT @ S EQUITY | Jul 28, 2026, 11:11 AM UTC L STAA Reiterating Wedbush's OUTPERFORM rating and $40 PT following advisor call earlier this week that in its view confirmed its long-term in STAA Reiterating Wedbush's OUTPERFORM rating and $40 PT following advisor call earlier this week that in its view confirmed its long-term investment thesis @ Wedbush EQUITY | Jul 22, 2026, 01:25 PM UTC H Intuitive Surgical, Netflix And Other Big Stocks Moving Lower In Friday’s Pre-Market Session U.S. stock futures were lower this morning, with the Nasdaq 100 futures falling around 2% on Friday. Shares of Intuitive Surgical Inc (NASDAQ: ISRG ) fell sharply in pre-market trading after the company reported second-q EARNINGS | Jul 17, 2026, 12:02 PM UTC H Why Callan JMB Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket Shares of Callan JMB Inc (NASDAQ: CJMB ) rose sharply in pre-market trading following the announcement that Callan JMB signed a strategic partnership with Alabama State University to build an integrated pharmaceutical ma MACRO | Jul 17, 2026, 08:48 AM UTC L STAA guides Q2 prelim revs $90M vs. est. $90.25M saying growth was driven by China, broader Asia-Pacific, and double-digit gains in the Amer STAA guides Q2 prelim revs $90M vs. est. $90.25M saying growth was driven by China, broader Asia-Pacific, and double-digit gains in the Americas while EMEA sales declined due to Middle East turmoil; company warns of ongo GEOPOLITICS | Jul 16, 2026, 08:29 PM UTC L STAA -8% post mkt after preliminary results STAA -8% post mkt after preliminary results EQUITY | Jul 16, 2026, 08:07 PM UTC L STAA - - Staar Surgical announces preliminary net sales for second quarter 2026 Staar Surgical Q2 sales $90M vs. EST $90.3M STAA - - Staar Surgical announces preliminary net sales for second quarter 2026 Staar Surgical Q2 sales $90M vs. EST $90.3M EQUITY | Jul 16, 2026, 08:04 PM UTC